Advanced Search

 

Study ID Status Title Patient Level Data
112352 Completed A 12-week Study to Evaluate the 24-hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg once daily Compared with Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg twice daily in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
112353 Completed Study to evaluate the safety and reactogenicity of the HIV Vaccine 732461 in HIV infected subjects aged 18 to 55 years old
112355 Completed A Randomized, Double-Blind, Parallel-Group, 16-Week Study to Evaluate the Effect of Fluticasone Propionate/Salmeterol DISKUS® 250/50mcg BID and Placebo on Arterial Stiffness in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
112356 Completed A randomised, double-blind, placebo-controlled, 3-period cross-over study to evaluate the effect of two doses of GSK2190915 on the allergen-induced early asthmatic response in subjects with mild asthma Study Listed on ClinicalStudyDataRequest.com
112359 Completed A single centre, randomised, double-blind, placebo-controlled, four-way cross over study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of GSK2190915 in healthy Japanese subjects. Study Listed on ClinicalStudyDataRequest.com
112362 Completed An open label, sequential, single cohort, repeat dose study to investigate the potential interaction of GSK2190915 on the pharmacokinetics of rosuvastatin in healthy adult subjects. Study Listed on ClinicalStudyDataRequest.com
112368 Completed Time trend analysis of diarrhea-related hospitalizations and deaths in children < 5 years of age in Brazil, 1990-2010
112382 Completed Equivalence Study on Flutide Aerosol –Double-blind Crossover Comparative Study with Inhaling Powder as a Comparator–
112387 Completed Imigran tablets Post Marketing Clinical study -An open-label, multi-center study to access the improvement in the health-related quality of life (HRQOL) of migraineurs with Imigran tablets 50- <Post Marketing Clinical Study>
112390 Completed A Post-Marketing Clinical Study of Paroxetine Hydrochloride Hydrate in Patients with Depression or Depressive Episode -A Double-Blind, Imipramine Hydrochloride-Controlled, Comparative Study -
112392 Completed Flutide Rotadisk (SN411D) Post Marketing Clinical study - Investigation of Efficacy/Safety of add-on of Flutide Rotadisk in Subjects with Bronchial Asthma (A Randomized, Open-label, Parallel group Study) -
112418 Completed Nadis Retrospective data analysis
112419 Completed Nadis retrospective data analysis
112437 Completed Osteoporosis: GPRD study - An assessment of GI associated adverse events associated with bisphophonates in the UK
112438 Completed A randomised, single-blind, placebo-controlled, study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of single ascending administration of otelixizumab in subjects with Type 1 Diabetes Mellitus
112455 Completed Muti-center, cross-sectional observational study for psychometry of Korean version of computerized Asthma-specific Quality of Life questionnaire
112477 Completed An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor the safety and effectiveness of TYKERB® tablets administered in Korean patients according to the prescribing information
112480 Terminated A randomised, comparator controlled, two part, open-label study to evaluate the safety, tolerability and pharmacodynamics of multiple doses of otelixizumab in patients with thyroid orbitopathy Study Listed on ClinicalStudyDataRequest.com
112483 Completed A single-centre, double-blind, placebo-controlled study to evaluate the safety, tolerabilty, pharmacokinetics, and pharmacodynamics of single, oral, ascending doses and repeat oral doses of GSK1325756 in healthy male subjects. Study Listed on ClinicalStudyDataRequest.com
112485 Completed Safety of GlaxoSmithKline (GSK) Biologicals’ human papillomavirus (HPV)-16/18 vaccine, Cervarix® when administered to healthy females according to the prescribing information in Korea
112487 Terminated A randomised, double-blind, placebo controlled, parallel group , flexible dose study to evaluate the efficacy and safety of Paxil® Tablets in children and adolescents with Major Depressive Disorder<Post-marketing clinical study> Study Listed on ClinicalStudyDataRequest.com
112495 Completed A Double-Blind, Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy of TREXIMA™* in the Acute Treatment of Migraine Headaches Study Listed on ClinicalStudyDataRequest.com
112496 Completed A Double-Blind, Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy of TREXIMA™*in the Acute Treatment of Migraine Headaches Study Listed on ClinicalStudyDataRequest.com
112497 Completed An Open-Label, Repeat Dose Study of the Safety of Combo Formulation in the Treatment of Multiple Episodes of Acute Migraine Over 12 Months. Study Listed on ClinicalStudyDataRequest.com
112509 Completed Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects with Advanced Myelodysplastic Syndrome (MDS) or secondary Acute Myeloid Leukemia after MDS (sAML/MDS)

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.